Approaching a new age in Duchenne muscular dystrophy treatment.
about
Current and emerging treatment strategies for Duchenne muscular dystrophyMuscle-bound primordial stem cells give rise to myofiber-associated myogenic and non-myogenic progenitorsChronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice.Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy.Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trial.Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilizationWhat has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways.Influence of Botulinumtoxin A on the Expression of Adult MyHC Isoforms in the Masticatory Muscles in Dystrophin-Deficient Mice (Mdx-Mice).Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy.Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.
P2860
Q26741535-A95EE7E3-C56D-4C48-87C3-BA1504D39E23Q27318008-CFF67F23-E2EA-4741-B077-4C6E87C852C6Q33952122-570F76C5-E165-4CE6-BAEE-145F9A3F9375Q34124872-E0BBEEC8-A9C3-44FD-A038-BDDC59FB158EQ35100498-73D4F963-B5B2-4908-99BE-6B899A6416AAQ35835703-72F05760-E53D-4688-AEBF-BE4D15169B5AQ36761839-DBD2DC20-7AB3-4ADC-964D-BCE7C981CD3DQ36997293-DE8F47B4-D61B-4E28-9F6B-6541C43BD44FQ38351283-3AA1C66F-A948-4F85-9109-DD8C70FA6AAFQ39750564-F3B8F79E-7570-439B-ABB7-395E00C5AAA3Q41096343-B45721F2-9B8D-486B-B0E2-87B4BC505425Q42133691-D13B6A88-4EAA-4756-9557-0A537D6F9C06Q51502053-03465572-EB63-493F-81D2-DCCD14FE90E8
P2860
Approaching a new age in Duchenne muscular dystrophy treatment.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Approaching a new age in Duchenne muscular dystrophy treatment.
@ast
Approaching a new age in Duchenne muscular dystrophy treatment.
@en
type
label
Approaching a new age in Duchenne muscular dystrophy treatment.
@ast
Approaching a new age in Duchenne muscular dystrophy treatment.
@en
prefLabel
Approaching a new age in Duchenne muscular dystrophy treatment.
@ast
Approaching a new age in Duchenne muscular dystrophy treatment.
@en
P2860
P1433
P1476
Approaching a new age in Duchenne muscular dystrophy treatment.
@en
P2093
Kathryn R Wagner
P2860
P2888
P304
P356
10.1016/J.NURT.2008.08.013
P577
2008-10-01T00:00:00Z
P5875
P6179
1049001851